Bausch + Lomb Corporation (BLCO) has released an update.
Bausch + Lomb Corporation has introduced Blink NutriTears, a new dietary supplement for dry eye relief in the U.S., promising to address root causes and improve symptoms within weeks. This nutritional approach to eye health is expected to complement the existing dry eye treatments and cater to the growing number of younger adults affected by dry eye due to digital screen use and other modern stressors. Available soon both in stores and online, Blink NutriTears combines ingredients like lutein and vitamin D for a clinically supported improvement in tear film stability.
For further insights into BLCO stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
